We are pleased to invite submissions for a Special Issue on coronavirus/COVID-19 research. Learn more
Recognizing the need for greater reproducibility in scientific research, our collaborating journals encourage their
authors to publish step-by-step methods in Bio-protocol/Bio-101.
Why contribute to and use Bio-101?
Contributing to
Bio-101 is
easy and free!

To save authors' time, protocols can be submitted in any format and our dedicated editing team will format the protocols for the authors. Contributions are free of charge.
formatting and
user-driven feedback

Each protocol undergoes proofreading by our editorial team to ensure both quality and clarity. Following this, users can provide feedback and suggestions using our commenting system, enabling post-release updates.
Something missing?
Submit a request!

Users can request new protocols to be written using our "Protocol Request" system, which will then be fielded by our team of Associate Editors or volunteers from the userbase.
New: Protocol for Peptide Synthesis on Spectrally Encoded Beads for MRBLE-pep Assays http://bio-protocol.org/e3669 This approach reduces the amount of protein and peptide needed and time required to measure protein-peptide affinities compared to traditional #methods. @Stanford @eLife
Twitter • -14 hours ago
New: Observing Nutrient Gradients, Gene Expression and Growth Variation Using the "Yeast Machine" Microfluidic Device http://bio-protocol.org/e3668 @CVulin @p_R100 and colleagues share a microfluidic device for inferring metabolic landscapes in monolayer colonies #microbiology @eLife
Twitter • 3 hours ago
New: In vivo Mouse Mammary Gland Formation http://bio-protocol.org/e3667 This #protocok includes instructions for preparing “cleared” recipients and mammary cells for implantation, the surgery process, and how to assess the experimental results. #stemcells @jbiolchem
Twitter • 1 day ago
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.